Search

everythinglearnresearchcommunity

for

Search:↓

Effective treatments for male pattern baldness include oral finasteride and topical minoxidil, while topical minoxidil is best for female pattern baldness.

Antiandrogens are somewhat effective in reducing excessive hair growth in women.

Use minoxidil for hair loss treatment; assess results after 6 months.

K_ATP channel gene mutations are linked to heart diseases, but more research is needed to understand the connection and treatment potential.

Memory regulatory T cells need IL-7, not IL-2, to stay in peripheral tissues.

Finasteride treats enlarged prostate and hair loss, but may cause side effects in some patients.

Men generally have more severe COVID-19 cases and higher death rates than women due to biological differences.

Finasteride effectively treats baldness but may cause sexual side effects.

Finasteride and minoxidil are effective for hair regrowth, while treatments for alopecia areata have varying success and continuous treatment is necessary.

The update highlights that non-classic congenital adrenal hyperplasia is common in women with excess male hormones, requires specific hormone tests for diagnosis, and has various treatment options depending on age and symptoms.

Minoxidil is the only FDA-approved topical drug for treating male or female pattern hair loss, and other medications like finasteride and dutasteride can also increase hair growth.

Finasteride with oral contraceptive helps improve hair loss in premenopausal women.

The document concludes that proper diagnosis and a multidisciplinary approach are crucial for managing Congenital Adrenal Hyperplasia effectively.

Medications have become the main treatment for enlarged prostate symptoms, replacing surgery and watchful waiting.

Finasteride improves hair loss in women with hyperandrogenism.

The document concludes that accurate diagnosis of different types of hair loss requires careful examination of hair and scalp tissue, considering both clinical and microscopic features.

The document concludes that early diagnosis and treatment of Congenital Adrenal Hyperplasia are crucial for preventing serious health issues and improving patient outcomes.

Women with PCOS may take longer to get pregnant but can have a normal family size, and should manage their overall health to reduce long-term health risks.

Pregnancy can increase lupus activity, but careful planning and treatment can improve outcomes.

The document concludes that hirsutism is the main sign for diagnosing hyperandrogenism, which requires a detailed patient history and physical exam.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

Effective hair loss treatment in women requires correct diagnosis and can include medications like minoxidil, antiandrogens, and treatments for underlying conditions like PCOS.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

Women with PCOS often have skin problems like excessive hair, acne, hair loss, and dark patches, which can be treated with hormonal and non-hormonal therapies.

Minoxidil and finasteride are effective for male hair loss, minoxidil for female hair loss, and various treatments like corticosteroids work for alopecia areata; treatment should be tailored to the individual.

Teriflunomide is safe and tolerable for treating relapsing-remitting multiple sclerosis, with manageable side effects.

The conclusion is that recognizing hair growth cycles can improve the precision of dietary and health assessments from hair analysis.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

Human hair follicles produce and respond to erythropoietin, helping protect against stress.

Treatment with plasma rich in growth factors improved hair density and thickness for hair loss patients.